XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)

Original price was: $249.00.Current price is: $5.00.

By DrugPatentWatch XARELTO Drug Profile, 2024 This report focuses on XARELTO and covers the following critical aspects of this drug: United States patents Expired United States patents FDA Paragraph IV patent challenges District Court patent litigation Patent Trial and Appeal Board (PTAB) patent cases European supplementary protection certificates (SPCs) Clinical trials Drug prices Annual sales revenues Finished product suppliers Raw active pharmaceutical ingredient (API) sources FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free update Product Details ASIN ‏ : ‎ B0CS997FGD Publisher ‏ : ‎ Independently published (January 12, 2024) Language ‏ : ‎ English…

SKU: MED-AMB146787
Category:
Tags:

Description

By DrugPatentWatch
XARELTO Drug Profile, 2024

This report focuses on XARELTO and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free update

Product Details

  • ASIN ‏ : ‎ B0CS997FGD
  • Publisher ‏ : ‎ Independently published (January 12, 2024)
  • Language ‏ : ‎ English
  • Paperback ‏ : ‎ 584 pages
  • ISBN-13 ‏ : ‎ 979-8875923647

Reviews

There are no reviews yet.

Be the first to review “XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)”

Your email address will not be published. Required fields are marked *